LONDON (Reuters) - The chief executive of Smith & Nephew (SN.L) said on Friday that M&A was not at the top of his agenda, as the focus was on driving growth at the artificial knee and hip maker.
A report in the Financial Times in March said Wright Medical (WMGI.O), a U.S. company that specialize in surgical implants for extremities like feet and ankles, could be a takeover target for the British company.
S&N Chief Executive Olivier Bohuon said M&A was “always on the agenda”, and he had previously pointed to extremities as one of a number of areas of interest.
“But for the moment, this quarter, I am interested in developing my commercial excellence,” he said.
“(M&A) is still high on the agenda, but it’s not a top priority for the time being.”
Reporting by Paul Sandle; editing by Kate Holton